>
|
 |
ġ 'ػ', ù Դ Ͼ 㰡
|
|
|
|
|
|
|
Դ ϰ ġ ִ ο ġ ľû 㰡 Ҵ. ۸ Ǽ ڣ
̿ コɾ Դ ġ ػ١ (18) ǰǾǰûκ 㰡 Ҵٰ .
ػٴ ѱ ̱, 60 ༺ ġ , Ǹŵǰ ġδ 10, 11 ̱ Դ ġ ִ.
, ̽, , ġ κ ġḸ ƴµ ̹ ػ ߰ Ͽ ϰ ƴ.
ػٴ ϼ ϼ ϴ Ǽ ÿ ϴ ǥ ϼ , Ѵ.
Դ Կ ʰ ġᰡ ϸ ̰ ϼ ϴ ǥ ȿ ̰ ۿ ٿ.
̿ コɾ(̿) ϻ γ ڻ ġ ġ ȸ ġ ȯڵ Ҵ١ Դ ġ ػ 㰡 ġ ο Ⱑ õƴ١ ػ 㰡 Ǹ .
Ϸ翡 ħ, 2˾ 2ȸ ϸ ۿ , ڸ, Ƿ, հ ߿ Ÿ ۿ, Ż, Ž ̴.
̹ Դ ġ Ͽ ġḦ 602 ȯڸ ٱ, , 3 ӻ (SHARP, Sorafenib HCC Assessment Randomized Protocol) ػ 뱺 ౺ 44% ϰ Ÿ.
ػ 뱺 Ⱓ ߾Ӱ 10.7 ̾ 뱺 7.9̾.
̹ ػ 3 ӻ SHARP 323~326ϱ COEX ƽþ 2500 ֵǴ ƽþ簣ȸ(APASL, Asia-Pacific Association for the Study of the Liver) Ұȴ.
2002 ѱ߾Ӿϵ迡 ϸ ظ 11000 ȯڰ ϰ Ư 40~50 1 ϰ ִ.
Ǽ (sun3005@mdtoday.co.kr)
<ǰ ̴ ѹα ǥ Ƿ, ǰ Ź , >
|
|
|
 |
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
- 1ȸ , ̱ տ
- , ڷγ19 ν
- ġ, Ư к ȸ ִ ȯ
- Ʈ, 236 60.3%
- ȸ ̿ǻƽ, 140 Ը øA ġ
- ̵, ̸Ͱ ༺ ĺ
- , κ ǡ ڿջ ӿ ǰῡ
- ľó , 彺 м
- Ʈ, ڷγ19 üġ ӻ ⡦
- ѱν, ̺ ȿ ġ ɼ
|
|
|
|
    |
|
|
|
|